The Molecular Functions of MeCP2 in Rett Syndrome Pathology

被引:21
|
作者
Sharifi, Osman [1 ]
Yasui, Dag H. [1 ]
机构
[1] Univ Calif Davis, Dept Med Microbiol & Immunol, LaSalle Lab, Sch Med, Davis, CA 95616 USA
关键词
Rett syndrome; epigenetic; DNA; chromatin; gene expression; MeCP2; CPG-BINDING PROTEIN-2; MOUSE MODEL; TRANSCRIPTIONAL REPRESSOR; L1; RETROTRANSPOSITION; NEURONAL MECP2; CHROMATIN; DNA; MUTATIONS; MICE; DOMAIN;
D O I
10.3389/fgene.2021.624290
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MeCP2 protein, encoded by the MECP2 gene, binds to DNA and affects transcription. Outside of this activity the true range of MeCP2 function is still not entirely clear. As MECP2 gene mutations cause the neurodevelopmental disorder Rett syndrome in 1 in 10,000 female births, much of what is known about the biologic function of MeCP2 comes from studying human cell culture models and rodent models with Mecp2 gene mutations. In this review, the full scope of MeCP2 research available in the NIH Pubmed () data base to date is considered. While not all original research can be mentioned due to space limitations, the main aspects of MeCP2 and Rett syndrome research are discussed while highlighting the work of individual researchers and research groups. First, the primary functions of MeCP2 relevant to Rett syndrome are summarized and explored. Second, the conflicting evidence and controversies surrounding emerging aspects of MeCP2 biology are examined. Next, the most obvious gaps in MeCP2 research studies are noted. Finally, the most recent discoveries in MeCP2 and Rett syndrome research are explored with a focus on the potential and pitfalls of novel treatments and therapies.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Duplication of MECP2 in a girl with Rett syndrome variant
    Jansen, A.
    De Rademaeker, M.
    De Meirleir, L.
    Seneca, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 243 - 243
  • [32] MECP2 mutations in Serbian Rett syndrome patients
    Djarmati, A.
    Dobricic, V.
    Kecmanovic, M.
    Marsh, P.
    Jancic-Stefanovic, J.
    Klein, C.
    Djuric, M.
    Romac, S.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (06): : 413 - 419
  • [33] MeCP2: Making sense of missense in Rett syndrome
    Abhishek Banerjee
    Esmeralda Romero-Lorenzo
    Mriganka Sur
    Cell Research, 2013, 23 : 1244 - 1246
  • [34] Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action
    Bedogni, Francesco
    Rossi, Riccardo L.
    Galli, Francesco
    Gigli, Clementina Cobolli
    Gandaglia, Anna
    Kilstrup-Nielsen, Charlotte
    Landsberger, Nicoletta
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 187 - 201
  • [35] Impact of Rett Syndrome Mutations on MeCP2 MBD Stability
    Kucukkal, Tugba G.
    Yang, Ye
    Uvarov, Olga
    Cao, Weiguo
    Alexov, Emil
    BIOCHEMISTRY, 2015, 54 (41) : 6357 - 6368
  • [36] Ckassic Rett syndrome in a boy with MECP2 mutation.
    Kondo, I
    Masuyama, T
    Matsuo, S
    Kitsuki, K
    Kan, Y
    Ishii, K
    Yamagata, H
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 258 - 258
  • [37] Spectrum of MECP2 mutations in Vietnamese patients with RETT syndrome
    Huong Le Thi Thanh
    Trinh Do Thi Diem
    Chinh Vu Duy
    Ha Ly Thi Thanh
    Hoa Bui Thi Phuong
    Liem Nguyen Thanh
    BMC MEDICAL GENETICS, 2018, 19
  • [38] Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients:: a molecular update
    Philippe, C
    Villard, L
    De Roux, N
    Raynaud, A
    Bonnefond, JP
    Pasquier, L
    Lesca, G
    Mancini, J
    Jonveaux, P
    Moncla, A
    Chelly, J
    Bienvenu, J
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2006, 49 (01) : 9 - 18
  • [39] Rett Syndrome and the Role of MECP2: Signaling to Clinical Trials
    Lopes, Adele Gaspar
    Loganathan, Sampath Kumar
    Caliaperumal, Jayalakshmi
    BRAIN SCIENCES, 2024, 14 (02)
  • [40] Magnetic resonance spectroscopy and analysis of MECP2 in Rett syndrome
    Khong, PL
    Lam, CW
    Ooi, CGC
    Ko, CH
    Wong, VCN
    PEDIATRIC NEUROLOGY, 2002, 26 (03) : 205 - 209